Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Loebinger

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Lung|July 15, 2017
The Objective Assessment of Cough Frequency in BronchiectasisArietta Spinou, Kai K Lee, Aish Sinha, et al.
NPJ Primary Care Respiratory Medicine|June 29, 2019
Primary care implications of the British Thoracic Society Guidelines for bronchiectasis in adults 2019Kevin Gruffydd-Jones, Duncan Keeley, Vikki Knowles, et al.
The European Respiratory Journal|May 13, 2017
The development and validation of the Bronchiectasis Health QuestionnaireArietta Spinou, Richard J Siegert, Wei-Jie Guan, et al.
Respiration; International Review of Thoracic Diseases|April 25, 2021
The Primary Ciliary Dyskinesia Computed Tomography Score in Adults with Bronchiectasis: A Derivation und Validation StudyJessica Rademacher, Sabine Dettmer, Jan Fuge, et al.
ERJ Open Research|January 28, 2025
Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trialJames D Chalmers, Michael R Loebinger, Ariel Teper, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 26, 2023
The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmissionRebekah M Dedrick, Lawrence Abad, Nathaniel Storey, et al.
Pulmonary Pharmacology & Therapeutics|August 22, 2019
Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)Michael R Loebinger, Eva Polverino, Francesco Blasi, et al.
International Journal of Molecular Sciences|November 18, 2016
Characterizing Non-Tuberculous Mycobacteria Infection in BronchiectasisPaola Faverio, Anna Stainer, Giulia Bonaiti, et al.
Chronic Respiratory Disease|June 18, 2020
Anxiety and depression in bronchiectasis: Response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression ScaleStephanie C Wynne, Suhani Patel, Ruth E Barker, et al.
Plos One|February 8, 2017
Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patientsMichael J Cox, Elena M Turek, Catherine Hennessy, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Lung|July 15, 2017
The Objective Assessment of Cough Frequency in BronchiectasisArietta Spinou, Kai K Lee, Aish Sinha, et al.
NPJ Primary Care Respiratory Medicine|June 29, 2019
Primary care implications of the British Thoracic Society Guidelines for bronchiectasis in adults 2019Kevin Gruffydd-Jones, Duncan Keeley, Vikki Knowles, et al.
The European Respiratory Journal|May 13, 2017
The development and validation of the Bronchiectasis Health QuestionnaireArietta Spinou, Richard J Siegert, Wei-Jie Guan, et al.
Respiration; International Review of Thoracic Diseases|April 25, 2021
The Primary Ciliary Dyskinesia Computed Tomography Score in Adults with Bronchiectasis: A Derivation und Validation StudyJessica Rademacher, Sabine Dettmer, Jan Fuge, et al.
ERJ Open Research|January 28, 2025
Brensocatib in patients with bronchiectasis: subgroup analyses from the WILLOW trialJames D Chalmers, Michael R Loebinger, Ariel Teper, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 26, 2023
The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmissionRebekah M Dedrick, Lawrence Abad, Nathaniel Storey, et al.
Pulmonary Pharmacology & Therapeutics|August 22, 2019
Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1)Michael R Loebinger, Eva Polverino, Francesco Blasi, et al.
International Journal of Molecular Sciences|November 18, 2016
Characterizing Non-Tuberculous Mycobacteria Infection in BronchiectasisPaola Faverio, Anna Stainer, Giulia Bonaiti, et al.
Chronic Respiratory Disease|June 18, 2020
Anxiety and depression in bronchiectasis: Response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression ScaleStephanie C Wynne, Suhani Patel, Ruth E Barker, et al.
Plos One|February 8, 2017
Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patientsMichael J Cox, Elena M Turek, Catherine Hennessy, et al.
Pageof 15